e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Complex respiratory infections in clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria.
A. Russkikh (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
Source:
International Congress 2019 – Complex respiratory infections in clinical practice
Session:
Complex respiratory infections in clinical practice
Session type:
Thematic Poster
Number:
4586
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Russkikh (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation). Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria.. 4586
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005
Pulmonary function before and early after endobronchial valve placement in patients with chronic cavitary tuberculosis
Source: International Congress 2019 – Interventional pulmonology: re-sculpting the airway
Year: 2019
Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021
Non-tuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019
Year: 2019
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009
Endobronchial valve application in treatment of drug-resistant lung tuberculosis
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Atypical pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Application of the endobronchial valve in complex treatment of drug-resistant lung tuberculosis
Source: Annual Congress 2010 - Video-assisted thorascopic surgery, novel technical devices and tracheal problems
Year: 2010
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Surgery in nontuberculous mycobacteria pulmonary disease
Source: Breathe, 14 (4) 288; 10.1183/20734735.027218
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept